{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:44:45Z","timestamp":1786985085502,"version":"build-2736575974"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010618","name":"Guangzhou University of Chinese Medicine","doi-asserted-by":"publisher","award":["A1-2601-25-415-111Z56"],"award-info":[{"award-number":["A1-2601-25-415-111Z56"]}],"id":[{"id":"10.13039\/501100010618","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010618","name":"Guangzhou University of Chinese Medicine","doi-asserted-by":"publisher","award":["BZ2021-033-01"],"award-info":[{"award-number":["BZ2021-033-01"]}],"id":[{"id":"10.13039\/501100010618","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010618","name":"Guangzhou University of Chinese Medicine","doi-asserted-by":"publisher","award":["20240417001"],"award-info":[{"award-number":["20240417001"]}],"id":[{"id":"10.13039\/501100010618","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010883","name":"Traditional Chinese Medicine Bureau of Guangdong Province","doi-asserted-by":"publisher","award":["20252033"],"award-info":[{"award-number":["20252033"]}],"id":[{"id":"10.13039\/501100010883","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010883","name":"Traditional Chinese Medicine Bureau of Guangdong Province","doi-asserted-by":"publisher","award":["20241122"],"award-info":[{"award-number":["20241122"]}],"id":[{"id":"10.13039\/501100010883","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010256","name":"Guangzhou Municipal Science and Technology Project","doi-asserted-by":"publisher","award":["2024A03J0130"],"award-info":[{"award-number":["2024A03J0130"]}],"id":[{"id":"10.13039\/501100010256","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010256","name":"Guangzhou Municipal Science and Technology Project","doi-asserted-by":"publisher","award":["2025A03J2927"],"award-info":[{"award-number":["2025A03J2927"]}],"id":[{"id":"10.13039\/501100010256","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.bcp.2026.117760","type":"journal-article","created":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:19:53Z","timestamp":1769559593000},"page":"117760","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Identification of a novel chalcone derivative as ferroptosis inducer through targeting TrxR in prostate cancer"],"prefix":"10.1016","volume":"247","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1552-8003","authenticated-orcid":false,"given":"Jun","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing-qing","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiao-xuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-biao","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-qiao","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng-wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fen","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-feng","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian-zhang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bcp.2026.117760_b0005","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.bcp.2026.117760_b0010","first-page":"34","article-title":"Where should enzalutamide be in the metastatic castration resistant prostate cancer (mCRPC): a multi-center study","volume":"7","author":"Sinan","year":"2023","journal-title":"Eura J Med Oncol"},{"issue":"4","key":"10.1016\/j.bcp.2026.117760_b0015","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/bju.15542","article-title":"Safety and survival of docetaxel and cabazitaxel in metastatic castration-resistant prostate cancer","volume":"129","author":"Kreis","year":"2022","journal-title":"BJU Int."},{"issue":"3","key":"10.1016\/j.bcp.2026.117760_b0020","doi-asserted-by":"crossref","DOI":"10.14440\/jbm.2024.0019","article-title":"Side effects of prostate cancer therapies and potential management","volume":"11","author":"Xiao","year":"2024","journal-title":"J. Biol. Methods"},{"issue":"10","key":"10.1016\/j.bcp.2026.117760_b0025","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1080\/13543784.2018.1513490","article-title":"Investigational therapies targeting the androgen signaling axis and the androgen receptor and in prostate cancer-recent developments and future directions","volume":"27","author":"Isaacsson Velho","year":"2018","journal-title":"Expert Opin. Investig. Drugs"},{"issue":"3","key":"10.1016\/j.bcp.2026.117760_b0030","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1210\/endrev\/bnab002","article-title":"Hormonal therapy for prostate cancer","volume":"42","author":"Desai","year":"2021","journal-title":"Endocr. Rev."},{"issue":"3","key":"10.1016\/j.bcp.2026.117760_b0035","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.jare.2014.05.002","article-title":"An unusual presentation of a patient with advanced prostate cancer, massive ascites and peritoneal metastasis: case report and literature review","volume":"6","author":"Petrakis","year":"2015","journal-title":"J. Adv. Res."},{"issue":"8","key":"10.1016\/j.bcp.2026.117760_b0040","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.trecan.2020.04.009","article-title":"Mitochondrial stress response and cancer","volume":"6","author":"O'Malley","year":"2020","journal-title":"Trends Cancer"},{"key":"10.1016\/j.bcp.2026.117760_b0045","doi-asserted-by":"crossref","DOI":"10.1002\/INMD.20240062","article-title":"Effects of reactive oxygen species and antioxidant strategies on wound healing in diabetes","volume":"3","author":"Yu","year":"2025","journal-title":"Interdiscip. Med."},{"issue":"12","key":"10.1016\/j.bcp.2026.117760_b0050","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1038\/s41416-023-02442-4","article-title":"The role of TXNIP in cancer: a fine balance between redox, metabolic, and immunological tumor control","volume":"129","author":"Deng","year":"2023","journal-title":"Br. J. Cancer"},{"issue":"8","key":"10.1016\/j.bcp.2026.117760_b0055","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/carcin\/bgac052","article-title":"Plasma thioredoxin reductase: a potential diagnostic biomarker for gastric cancer","volume":"43","author":"Zhu","year":"2022","journal-title":"Carcinogenesis"},{"issue":"1","key":"10.1016\/j.bcp.2026.117760_b0060","first-page":"2652","article-title":"Thioredoxin reductase as a novel and efficient plasma biomarker for the detection of non-small cell lung cancer: a large-scale","volume":"9","author":"Ye","year":"2019","journal-title":"Multicenter Study. Sci Rep"},{"issue":"9","key":"10.1016\/j.bcp.2026.117760_b0065","first-page":"2788","article-title":"Oxidative stress measured by thioredoxin reductase level as potential biomarker for prostate cancer","volume":"5","author":"Zhang","year":"2015","journal-title":"Am. J. Cancer Res."},{"issue":"8","key":"10.1016\/j.bcp.2026.117760_b0070","doi-asserted-by":"crossref","first-page":"555","DOI":"10.56434\/j.arch.esp.urol.20237608.69","article-title":"The value of combined detection of Serum PSA, MALAT1 and TMPRSS2-ETV1 in evaluating the progress and prognosis of prostate cancer","volume":"76","author":"Zhao","year":"2023","journal-title":"Arch. Esp. Urol."},{"key":"10.1016\/j.bcp.2026.117760_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105854","article-title":"Thioredoxin reductase as a pharmacological target","volume":"174","author":"Bj\u00f8rklund","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bcp.2026.117760_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106134","article-title":"Expanding the armory for treating lymphoma: targeting redox cellular status through thioredoxin reductase inhibition","volume":"177","author":"Wang","year":"2022","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bcp.2026.117760_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113897","article-title":"Structure modification and biological evaluation of indole-chalcone derivatives as anti-tumor agents through dual targeting tubulin and TrxR","volume":"227","author":"Yan","year":"2022","journal-title":"Eur. J. Med. Chem."},{"issue":"16","key":"10.1016\/j.bcp.2026.117760_b0090","doi-asserted-by":"crossref","first-page":"7309","DOI":"10.1021\/acs.jmedchem.8b01595","article-title":"Targeting the thioredoxin system as a strategy for cancer therapy","volume":"62","author":"Bian","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bcp.2026.117760_b0095","article-title":"Advances in ferroptosis for castration-resistant prostate cancer treatment: novel drug targets and combination therapy strategies","author":"Chen","year":"2024","journal-title":"Prostate Cancer Prostatic Dis."},{"issue":"6","key":"10.1016\/j.bcp.2026.117760_b0100","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1158\/0008-5472.CAN-20-3477","article-title":"Ferroptosis inducers are a novel therapeutic approach for advanced prostate cancer","volume":"81","author":"Ghoochani","year":"2021","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.bcp.2026.117760_b0105","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/s12967-025-06180-4","article-title":"Targeting ferroptosis in prostate cancer management: molecular mechanisms, multidisciplinary strategies and translational perspectives","volume":"23","author":"Yang","year":"2025","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.bcp.2026.117760_b0110","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/s41420-023-01430-0","article-title":"Ferroptosis landscape in prostate cancer from molecular and metabolic perspective","volume":"9","author":"Liang","year":"2023","journal-title":"Cell Death Discov"},{"key":"10.1016\/j.bcp.2026.117760_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.ecoenv.2025.118209","article-title":"Revealing the role of bisphenol A on prostate cancer progression and identifying potential targets: a comprehensive analysis from population cohort to molecular mechanism","volume":"296","author":"Zhou","year":"2025","journal-title":"Ecotoxicol. Environ. Saf."},{"issue":"13","key":"10.1016\/j.bcp.2026.117760_b0120","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1016\/j.cell.2023.05.003","article-title":"Ferroptosis surveillance independent of GPX4 and differentially regulated by sex hormones","volume":"186","author":"Liang","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2026.117760_b0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2023.100985","article-title":"Inhibition of phosphoglycerate dehydrogenase induces ferroptosis and overcomes enzalutamide resistance in castration-resistant prostate cancer cells","volume":"70","author":"Wang","year":"2023","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.bcp.2026.117760_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105305","article-title":"Flubendazole, FDA-approved anthelmintic, elicits valid antitumor effects by targeting P53 and promoting ferroptosis in castration-resistant prostate cancer","volume":"164","author":"Zhou","year":"2021","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.bcp.2026.117760_b0135","doi-asserted-by":"crossref","first-page":"22","DOI":"10.2478\/jtim-2023-0137","article-title":"Ferroptosis in organ fibrosis: from mechanisms to therapeutic medicines","volume":"12","author":"Lai","year":"2024","journal-title":"J. Transl. Int. Med."},{"key":"10.1016\/j.bcp.2026.117760_b0140","doi-asserted-by":"crossref","DOI":"10.1002\/INMD.20220010","article-title":"Advanced strategic constructions of diketopyrrolopyrrole derivatives\u2010based organic semiconducting phototheranostics","volume":"1","author":"Wang","year":"2023","journal-title":"Interdiscip. Med."},{"key":"10.1016\/j.bcp.2026.117760_b0145","article-title":"A semi-quantitative drug affinity responsive target stability (DARTS) assay for studying Rapamycin\/mTOR interaction","volume":"150","author":"Zhang","year":"2019","journal-title":"J. Vis. Exp."},{"issue":"1","key":"10.1016\/j.bcp.2026.117760_b0150","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1038\/s41467-017-01243-7","article-title":"A potent small-molecule inhibitor of the DCN1-UBC12 interaction that selectively blocks cullin 3 neddylation","volume":"8","author":"Zhou","year":"2017","journal-title":"Nat. Commun."},{"issue":"19","key":"10.1016\/j.bcp.2026.117760_b0155","doi-asserted-by":"crossref","first-page":"11195","DOI":"10.1021\/acs.jmedchem.0c01128","article-title":"Design and SAR of withangulatin a analogues that act as covalent TrxR inhibitors through the michael addition reaction showing potential in cancer treatment","volume":"63","author":"Wang","year":"2020","journal-title":"J. Med. Chem."},{"issue":"3","key":"10.1016\/j.bcp.2026.117760_b0160","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/s41419-021-03516-y","article-title":"Induction of ferroptosis in human nasopharyngeal cancer cells by cucurbitacin B: molecular mechanism and therapeutic potential","volume":"12","author":"Huang","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bcp.2026.117760_b0165","doi-asserted-by":"crossref","first-page":"41510","DOI":"10.1039\/C4RA07998A","article-title":"The convenient aqueous synthesis and biological evaluation of ortho-(3,4,5-trimethoxybenzoyl)-acetanilides as novel anti-cancer agents","volume":"4","author":"Sheng","year":"2014","journal-title":"RSC Adv."},{"key":"10.1016\/j.bcp.2026.117760_b0170","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1016\/j.bmc.2017.03.066","article-title":"The synthesis and evaluation of new butadiene derivatives as tubulin polymerization inhibitors","volume":"25","author":"Pang","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bcp.2026.117760_b0175","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1039\/C5MD00139K","article-title":"Synthesis, biological evaluation and mechanism study of a class of benzylideneindanone derivatives as novel anticancer agents","volume":"6","author":"Hu","year":"2015","journal-title":"Med. Chem. Commun."},{"key":"10.1016\/j.bcp.2026.117760_b0180","doi-asserted-by":"crossref","first-page":"68128","DOI":"10.1039\/C5RA14888J","article-title":"Synthesis, biological evaluation and mechanism study of chalcone analogues as novel anti-cancer agents","volume":"5","author":"Chen","year":"2015","journal-title":"RSC Adv."},{"key":"10.1016\/j.bcp.2026.117760_b0185","doi-asserted-by":"crossref","first-page":"98527","DOI":"10.1039\/C5RA19270F","article-title":"Synthesis, biological evaluation and mechanism study of a class of cyclic combretastatin A-4 analogues as novel antitumour agents","volume":"5","author":"Yan","year":"2015","journal-title":"RSC Adv."},{"key":"10.1016\/j.bcp.2026.117760_b0190","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.ejmech.2016.09.056","article-title":"Design, synthesis, and biological evaluation of cyclic-indole derivatives as anti-tumor agents via the inhibition of tubulin polymerization","volume":"125","author":"Yan","year":"2017","journal-title":"Euro J. Med. Chem."},{"key":"10.1016\/j.bcp.2026.117760_b0195","doi-asserted-by":"crossref","first-page":"5264","DOI":"10.1021\/acs.jmedchem.6b00021","article-title":"Synthesis, evaluation, and mechanism study of novel indolechalcone derivatives exerting effective antitumor activity through microtubule destabilization in vitro and in vivo","volume":"59","author":"Yan","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bcp.2026.117760_b0200","doi-asserted-by":"crossref","DOI":"10.3389\/pore.2024.1611586","article-title":"Spatial distribution of tumor-associated macrophages in an orthotopic prostate cancer mouse model","volume":"30","author":"Grayson","year":"2024","journal-title":"Pathol. Oncol. Res."},{"issue":"1","key":"10.1016\/j.bcp.2026.117760_b0205","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1080\/13685538.2022.2053954","article-title":"Androgen deprivation therapy and depression in the prostate cancer patients: review of risk and pharmacological management","volume":"25","author":"Alwhaibi","year":"2022","journal-title":"Aging Male"},{"key":"10.1016\/j.bcp.2026.117760_b0210","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/bs.acr.2017.07.005","article-title":"Targeting the selenoprotein thioredoxin reductase 1 for anticancer therapy","volume":"136","author":"Arn\u00e9r","year":"2017","journal-title":"Adv. Cancer Res."},{"key":"10.1016\/j.bcp.2026.117760_b0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116507","article-title":"Synergistic targeting of TrxR1 and ATM\/AKT pathway in human colon cancer cells","volume":"174","author":"Shen","year":"2024","journal-title":"Biomed. Pharmacother."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226000912?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226000912?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T13:04:34Z","timestamp":1779109474000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295226000912"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":43,"alternative-id":["S0006295226000912"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2026.117760","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of a novel chalcone derivative as ferroptosis inducer through targeting TrxR in prostate cancer","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2026.117760","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117760"}}